VXRT - Vaxart Inc. Year-over-year net earnings per share growth for the last 12 months

Official company branding of Vaxart Corp (VXRT)

The intensity of quarterly EPS growth demonstrates the impact of geopolitical risks on international testing and material supplies, while 0.00 records a new level. The experienced management of Vaxart, Inc. (VXRT) is implementing innovative tablet vaccines through government subsidies, leveraging FDA support and high loyalty among clinical trial participants within the established biopharmaceutical ecosystem.

Vaxart Inc. (VXRT) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 07/19/2025

VXRT (Vaxart Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
- market capitalization statistics:
Summary company analysis:Vaxart Corp - VXRT
Flagship merchandise of Vaxart

This indicator measures the year-over-year quarterly dynamics of earnings per share, allowing for an assessment of capital scaling speed and fundamental business stability. For Vaxart, Inc. (VXRT), which develops tablet vaccines based on the VAAST platform, the current quarterly EPS rate serves as a marker for the effectiveness of commercializing its developments, where an upward trend confirms rising profitability but signals a risk of asset overvaluation.

Competitor analysis

Gilead Sciences Inc (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth curevac.com|Year-over-year earnings per share growth for the last twelve months Valneva Corp (VALN)|Year-over-year earnings per share growth for the last twelve months VIR (Vir Biotechnology)|Year-over-year earnings per share growth for the last twelve months TPOXX SIGA|EBS - Year-over-year net earnings per share growth for the last 12 months|AVIR: Year-over-year net earnings per share growth for the last 12 months|IVVD (Invivyd Inc) - Year-over-year earnings per share growth for the last 12 months|ENTA: Quarterly EPS earnings growth|INO (Inovio) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax Corp|Quarterly EPS earnings growth Kalaris Tx|Quarterly EPS earnings growth DYAI|Year-over-year earnings per share growth for the last twelve months NNVC (NanoViricides)|Quarterly EPS earnings growth TLPH (Talphera Corporation)|Year-over-year net earnings per share change for the last twelve months Cocrystal (COCP)|TRAW - Year-over-year earnings per share growth for the last twelve months|DWTX (Dogwood Therapeutics Inc.) - Year-over-year earnings per share growth for the last 12 months|Qualigen Therapeutics, Inc. (QLGN) - Year-over-year earnings per share growth for the last twelve months|AlloVir Inc - Year-over-year earnings per one share growth for the last 12 months|VBIV (VBI Vaccines) - Quarterly EPS earnings growth|VIRI: Year-over-year earnings per one share growth for the last 12 months